CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Horizon Health Care Consultants

Horizon Health Care Consultants is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

South Carolina Heart Center

South Carolina Heart Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Columbia, SC. To find more information about South Carolina Heart Center, please visit www.scheart.com

Aaron Diamond AIDS Research Center

Aaron Diamond AIDS Research Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GEM Health Care Services

GEM Health Care Services Inc. is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LUZ

LUZ is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.